Another hypothesis proposes that the PD-1 receptor within tumor cells may function as a tumor suppressor [20], indicating that blocking PD-1 could potentially promote tumor growth. Further research, including the investigation of gene mutations, is necessary to explore the relationship between these immune-related therapies and the development of T-cell lymphomas. The gene discussed is PDCD1; the disease is neoplasm.